At 180 days follow-up, death (HR 1.10, 95% CI 0.572.14) and heart failure rehospitalization (HR 1.30, 95% CI 0.891.88) did not differ compared with those in the placebo group
That means you can lift heavier, push more reps, and sustain greater training volumeall key drivers of muscle growth
Tirzepatide may cause serious side effects, including: Possible thyroid tumors, including cancer
Additionally, research to examine the newer and more potent weight-loss GLP-1 receptor agonists, semaglutide (Ozempic/Wegovy, Novo Nordisk) and tirzepatide (Mounjaro/Zepbound, Eli Lilly), would be particularly important.
Both have proven they can manufacture and distribute peptide therapies at scale